Advantage of autologous blood transfusion in surgery for hepatocellular carcinoma

doi:10.3748/wjg.v17.i32.3709

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 32

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3181)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

293

HTML

2522

Figures (1-2)

209

Tables (1-5)

157

Sum=3181

Aug 28, 2011 (publication date) through May 15, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Aug 28, 2011; 17(32): 3709-3715
Published online Aug 28, 2011. doi: 10.3748/wjg.v17.i32.3709

Table 1 Clinicopathological characteristics of patients of periods A and B with hepatocellular carcinoma

	Period A(1991-1994)	Period B(1995-2000)	P-value
	(n = 93)	(n = 201)	P-value
Clinical factors
Gender (male/female)	81/12	161/40	0.144
Age (yr)¹	61 ± 9	62 ± 9	0.102
HBs-Ag (±)	73/20	169/32	0.243
Anti-HCV Ab (±/unknown)	29/62/2	71/125/5	0.471
Child-Pugh classification (A/B)	79/14	160/41	0.275
Preoperative Hb (g/dL)¹	13.6 ± 1.5	13.3 ± 1.6	0.213
Tumor-related factors
Number of tumors (single/multiple)	70/23	146/55	0.635
Maximum tumor size (cm)¹	3.8 ± 2.7	4.1 ± 3.1	0.450
Vascular invasion (±)	83/10	172/29	0.388
Histological grade (I, II/III, IV/unknown)	40/41/12	89/92/20	0.975
Surgery-related factors
Procedure (nonanatomical/anatomical)	45/48	101/100	0.767
Operation time (min)¹	291 ± 144	295 ± 151	0.853
Resected liver volume (g)¹	218 ± 406	214 ± 289	0.925
Intraoperative blood loss (mL)¹	2190 ± 5689	1621 ± 2209	0.219

¹Data are expressed as number of patients and mean ± standard deviation. HBs-Ag: Hepatitis B surface antigen; Anti-HCV Ab: Anti-hepatic C virus antibody; Hb: Hemoglobin.

Citation: Tomimaru Y, Eguchi H, Marubashi S, Wada H, Kobayashi S, Tanemura M, Umeshita K, Doki Y, Mori M, Nagano H. Advantage of autologous blood transfusion in surgery for hepatocellular carcinoma. World J Gastroenterol 2011; 17(32): 3709-3715
URL: https://www.wjgnet.com/1007-9327/full/v17/i32/3709.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i32.3709